abs356.txt	background		self-expandable	metal	stents	are	often	used	for	the	palliativetreatment	of	dysphagia	in	patients	with	advanced	esophageal	cancer	and	ananticipated	limited	survival	due	to	previous	reports	a	high	rate	adverseevent	when	long-term	concerns	have	been	raised	regard	use	ofself-expandable	longer	aim	assess	role	withadvanced	that	survived	than	six	months	methods	retrospective	study	aself-expandable	stent	placement	time	greater	results	forty-two	were	followed	up	298	days	there	was	clinicalimprovement	all	however	59%	experienced	an	median	patency	236	endoscopic	management	attemptedin	related	adverse	events	clinical	success	rateof	100%	previously	treated	event	recurred	sevenpatients	multivariate	analysis	showed	strictures	traversable	withan	ultrathin	gastroscope	associated	higher	risk	(p=	0	035)	conclusions	stenting	esophagealcancer	is	prevalence	without	impacton	mortality	most	cases	can	be	managed	endoscopically
